Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: Urlman who wrote (361)	10/19/1998 10:02:00 AM
From: Apache Indian	Read Replies (1) \| Respond to of 1494

Only significant thing I saw in the report Nov 1998 - expect to start Phase IIB of memantine (neurpathic? pain? I'm not good with terms) Jan 1999 - expect to complet this trial Need 2.5 million to conduct this test company has only around $1.8-2 mil. Need to raise more cash. -------- I believe if they manage to raise this money (and I believe they will) this could be the last chance to grab NTII below a buck. cause that would then lead them to completing their Phase IIB, strongly feel it should be positive, also should find a marketing partner after that All in all, the next news on financing should take us out of the woods forever, (of course now if PhaseII B were unsucc. it would be ovver)